Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees Life Science Investing
Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association 2026 Congress Life Science Investing
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel's Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 Life Science Investing
Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens Technology Investing
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates Pharmaceutical Investing
PTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD Collaboration Life Science Investing
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027 Medical Device Investing
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference Life Science Investing
